Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 119,555 $ 123,634
Cash held in escrow 49,091 17,101
Real estate inventories 1,121,726 1,093,369
Goodwill 68,639 68,639
Other assets 107,873 134,009
Total assets 1,471,232 1,440,496
Liabilities    
Accounts payable 77,969 74,445
Accrued expenses and other liabilities 160,256 149,426
Line of credit facility, net 307,631 505,422
Senior notes, net 236,143 0
Total liabilities 782,880 730,177
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of December 31, 2023 and December 31, 2022, respectively 0 0
Common stock, $0.0001 par value, 500,000,000 shares authorized, 41,382,453 issued and 36,520,894 outstanding as of December 31, 2023, 42,110,794 issued and 40,884,268 outstanding as of December 31, 2022 4 4
Additional paid-in capital 465,290 497,598
Retained earnings 187,584 158,348
Total stockholders’ equity 652,878 655,950
Noncontrolling interests 35,474 54,369
Total equity 688,352 710,319
Total liabilities and equity 1,471,232 1,440,496
Related Party    
Assets    
Due from affiliates 4,348 3,744
Liabilities    
Notes Payable $ 881 $ 884